
Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Marinomed Biotech
Market Cap: €35.3m
A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.
MARI
€19.20
7D
2.1%
1Y
22.3%
Warimpex Finanz- und Beteiligungs
Market Cap: €24.4m
Operates as a real estate development and investment company in Austria, Germany, Hungary, Russia, and Poland.
WXF
€0.47
7D
-2.3%
1Y
-21.8%